Singer, Elizabeth <br/><br/>
Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia.  [electronic resource] 

 -  PloS one  2013 
 - e60562 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0060562  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers, Tumor--genetics<br/>CD4-Positive T-Lymphocytes--metabolism<br/>Cryopreservation<br/>Humans<br/>Immunohistochemistry<br/>Macrophages--metabolism<br/>Male<br/>Middle Aged<br/>Nanotechnology--methods<br/>Neutrophils--metabolism<br/>Peroxiredoxins--genetics<br/>Prostate--metabolism<br/>Prostatectomy<br/>Prostatic Hyperplasia--diagnosis<br/>Prostatic Neoplasms--diagnosis<br/>Protein Binding<br/>Staining and Labeling<br/>Stromal Cells--metabolism<br/>Thioredoxin Reductase 1--genetics<br/>Thioredoxin Reductase 2--genetics